Pharma Deals Review, Vol 2003, No 40 (2003)

Font Size:  Small  Medium  Large

Xenova Acquires KS Biomedix to Focus on Brain Cancer Drug

Business Review Editor

Abstract


Xenova entered into an agreement to acquire KS Biomedix, thus substantially expanding its Brain cancer drug product portfolio.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.